Diagnosing persistent blood eosinophilia in asthma with single blood eosinophil or exhaled nitric oxide level

An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F <scp>e</scp> _NO ) for Clinical Applications

Raed A. Dweik, Peter B. Boggs, Serpil C. Erzurum et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 2.4K citations

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

Héctor Ortega, Mark C. Liu, Ian Pavord et al. · New England Journal of Medicine · 2014 · 2.2K citations · Full text

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Ian Pavord, Stephanie Korn, Peter Howarth et al. · The Lancet · 2012 · 2.2K citations

Asthma, Severe Eosinophilic Asthma, Allergy +10

Cluster Analysis and Clinical Asthma Phenotypes

Pranabashis Haldar, Ian Pavord, Dominick Shaw et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 2K citations · Full text

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair et al. · The Lancet · 2016 · 1.3K citations

Asthma, Rheumatology, Placebo-controlled Phase 3 +9